HERA-CD137L

N/A

Report date: 2025/01/26 18:35:27

Base Information

Drug NameHERA-CD137L
Drug Alias Name4-1BB agonist (Apogenix)4-1BB costimulator (Apogenix)HERA-CD137L
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionTumor necrosis factor receptor superfamily member 9 stimulants
TargetsTumor necrosis factor receptor superfamily member 9
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesApogenix Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesApogenix Gmbh
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A